Sabine Teigelkamp, Legal Representative

Title: Sabine Teigelkamp: Innovator in Blood Coagulation Assays

Introduction

Sabine Teigelkamp is a notable inventor and legal representative based in Niederwalgern, Germany. She has made significant contributions to the field of blood coagulation through her innovative methods and technologies. Her work is particularly focused on improving the accuracy and efficiency of blood coagulation assays.

Latest Patents

Teigelkamp holds a patent for a method related to blood coagulation assays. This invention pertains to determining the activity of a proteolytic coagulation factor within a body fluid, such as whole blood or plasma. The method involves a reaction mixture that includes a sample and an activation agent designed to activate a proteolytic coagulation factor or the entire blood coagulation cascade. The invention evaluates the effect of this activation on a reagent system that comprises a cleavable moiety, which is associated with a chemiluminescent agent or a sensitizer agent. The relationship between these agents allows for enhanced detection of coagulation activity, making her invention a valuable asset in medical diagnostics.

Career Highlights

Teigelkamp is currently employed at Siemens Healthcare Diagnostics Products GmbH, where she continues to develop and refine diagnostic technologies. Her expertise in legal representation complements her innovative work, allowing her to navigate the complexities of patent law effectively.

Collaborations

Throughout her career, Teigelkamp has collaborated with esteemed colleagues, including Andreas Kappel and Andrea Lichte. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Sabine Teigelkamp's contributions to blood coagulation assays exemplify the intersection of innovation and legal expertise. Her work not only advances medical diagnostics but also highlights the importance of collaboration in the field of healthcare technology.